We have a ton of developments today in the Coronavirus Vaccine situation. What we do know is encouraging in many waysramping up vaccine production. What we dont know about the effectiveness is terrifying. It makes you wonder if the u. S. Needs to dramatically rethink the current Vaccine Distribution strategy. Lets start with the good news. Today johnson and johnson leased some promising data from its phase three clinical trials. The vaccine is 72 effective in the u. S. At preventing moderate to severe illness. Experts consider that a strong level of protection. Here is the potential worrying news. The company disclosed the data suggests the vaccine was less effective against the South Africa Covid Variant we have been dropping. Effectiveness dropped from 72 to 57 . Its called that because it was south africa was the first place it was found which is more contagious and resistant to the vaccines we have. Its already in the United States and appears to be spreading. The more contagious u